Prescott’s Inc. Announces Expansion into Anesthesia Specialty Service with Acquisition of Heartland Medical Sales & Service

Prescott’s, Inc. (“Prescott’s”), the leading provider of refurbishment, maintenance, repair and service work for surgical microscopes utilized in hospital operating rooms and ambulatory surgery centers and a portfolio company of Atlantic Street Capital (“ASC”), announced today its expansion into the anesthesia specialty service and support sector with the acquisition of Heartland Medical Sales & Service (“Heartland”).

Founded in 1998 by Bradly Rumph and headquartered in Louisville, KY, Heartland focuses on delivering reliable service, repair, refurbishment and sales of anesthesia machines and related equipment. As Heartland has grown, their equipment capabilities have expanded as well to include single replacement devices to the complete outfitting of surgery centers and other medical facilities and equipment rental, refurbishment, and repair services. Heartland remains dedicated to its roots as a service company which is a natural extension of Prescott’s business.

Dylan DiJulio, Chief Executive Officer of Prescott’s, commented, “We are thrilled to have Heartland join the Prescott’s family.  This will allow us to continue to provide our clients with superior technical service and support of specialized surgical equipment nationwide while expanding our service offering to a broader product expertise. The anesthesia category is a natural extension of our business given the operational similarity and highly specialized skill required to provide field service support and repair and reconditioning capabilities. Brad Rumph has built an impressive company perfectly aligned with our service focused model. We believe our existing client base will welcome the additional capabilities that further differentiate us as a market leader.”

Brad Rumph, President and co-founder of Heartland, said, “For nearly 25 years, our mission at Heartland has been to serve as a trusted service partner to healthcare providers to ensure their medical equipment is reliable, safe, and always operational. We are proud of our tech staff and entire team who now look forward to being a part of Prescott’s and helping to expand this natural extension of their business.”

Prescott’s investment in Heartland represents the first of several anticipated acquisitions in the anesthesia refurbishment, maintenance, repair and service sector as well as other related contractual outsourced service, repair and maintenance business models serving the hospitals, integrated delivery networks (IDNs), surgery centers and specialty practice environments.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.